Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study in Patients With Unresectable Hepatocellular Carcinoma (HCC) Receiving Treatment With LifePearl Microspheres Loaded With Doxorubicin

NCT02548780 is registered in ClinicalTrials.gov with Terumo Europe N.V. as lead sponsor.

NCT NCT02548780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02548780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study in Patients With Unresectable Hepatocellular Carcinoma (HCC) Receiving Treatment With LifePearl Microspheres Loaded With Doxorubicin
Lead sponsor
Terumo Europe N.V.
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2016
Completion date
October 18, 2019
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, hepatocellular carcinoma